id	sid	eid	entity	type
bjos-8666337	1	1	1	CARDINAL
bjos-8666337	1	2	21 2022	CARDINAL
bjos-8666337	1	3	braz j	WORK_OF_ART
bjos-8666337	1	4	sci	ORG
bjos-8666337	2	1	2022;21	TIME
bjos-8666337	2	2	e226337http://dx.doi.org/10.20396	ORG
bjos-8666337	2	3	1	CARDINAL
bjos-8666337	2	4	tehran university of medical sciences	ORG
bjos-8666337	2	5	tehran	GPE
bjos-8666337	2	6	iran	GPE
bjos-8666337	3	1	2	CARDINAL
bjos-8666337	3	2	razi	PERSON
bjos-8666337	3	3	serum research institute	ORG
bjos-8666337	3	4	karaj	GPE
bjos-8666337	3	5	iran	GPE
bjos-8666337	4	1	3	CARDINAL
bjos-8666337	4	2	imam khomeini hospital	PERSON
bjos-8666337	4	3	tehran university of medical science	ORG
bjos-8666337	4	4	tehran	GPE
bjos-8666337	4	5	iran	GPE
bjos-8666337	5	1	soheila manifar	PERSON
bjos-8666337	5	2	imam khomeini hospital	PERSON
bjos-8666337	5	3	tehran university of medical science	ORG
bjos-8666337	5	4	tehran	GPE
bjos-8666337	5	5	iran	GPE
bjos-8666337	7	1	kargar st,	GPE
bjos-8666337	7	2	tehran	GPE
bjos-8666337	7	3	iran po.	GPE
bjos-8666337	7	4	14399-55991	CARDINAL
bjos-8666337	7	5	433	CARDINAL
bjos-8666337	8	1	altair a. del bel	PERSON
bjos-8666337	8	2	july 10, 2021	DATE
bjos-8666337	8	3	april 2	DATE
bjos-8666337	8	4	2022	CARDINAL
bjos-8666337	8	5	hpv-16	ORG
bjos-8666337	8	6	maryam koopaie1	FAC
bjos-8666337	8	7	mohamad amin nematollahi1	PERSON
bjos-8666337	8	8	maryam dadar2	PERSON
bjos-8666337	8	9	manifar3	PERSON
bjos-8666337	11	1	hpv-16	ORG
bjos-8666337	11	2	hpv-18	ORG
bjos-8666337	11	3	two	CARDINAL
bjos-8666337	14	1	15	CARDINAL
bjos-8666337	14	2	15	CARDINAL
bjos-8666337	20	1	three	CARDINAL
bjos-8666337	20	2	two	CARDINAL
bjos-8666337	20	3	30	CARDINAL
bjos-8666337	22	1	-18 e6	ORG
bjos-8666337	23	1	hpv-18	ORG
bjos-8666337	24	1	iranian	NORP
bjos-8666337	25	1	iranian	NORP
bjos-8666337	29	1	alphapapillomavirus	PERSON
bjos-8666337	31	1	2	CARDINAL
bjos-8666337	32	1	braz j	PERSON
bjos-8666337	32	2	sci	ORG
bjos-8666337	33	1	2022;21	TIME
bjos-8666337	33	2	90%	PERCENT
bjos-8666337	33	3	about 400000	CARDINAL
bjos-8666337	33	4	year1	PERSON
bjos-8666337	34	1	1.5	CARDINAL
bjos-8666337	34	2	hnscc2	ORG
bjos-8666337	35	1	differences3	ORG
bjos-8666337	36	1	india	GPE
bjos-8666337	36	2	pakistan	GPE
bjos-8666337	36	3	asia1,4	ORG
bjos-8666337	39	1	swelling5	ORG
bjos-8666337	40	1	hnscc	ORG
bjos-8666337	42	1	hnscc6,7	GPE
bjos-8666337	43	1	factors8	DATE
bjos-8666337	44	1	hpv	ORG
bjos-8666337	45	1	about 30	CARDINAL
bjos-8666337	45	2	lesions9	GPE
bjos-8666337	46	1	hpv-18	ORG
bjos-8666337	47	1	4	CARDINAL
bjos-8666337	47	2	14	CARDINAL
bjos-8666337	47	3	respectively12	PERSON
bjos-8666337	48	1	iran	GPE
bjos-8666337	49	1	hpv-16	ORG
bjos-8666337	49	2	hpv-18	ORG
bjos-8666337	49	3	iranian	NORP
bjos-8666337	50	1	iran	GPE
bjos-8666337	51	1	hpv-16	ORG
bjos-8666337	51	2	hpv-18	ORG
bjos-8666337	51	3	iranian	NORP
bjos-8666337	51	4	hpv-16	ORG
bjos-8666337	51	5	hpv-18	ORG
bjos-8666337	53	1	the tehran university of medical sciences ethical committee	ORG
bjos-8666337	55	1	imam khomeini hospital	GPE
bjos-8666337	55	2	tehran university of medical sciences	ORG
bjos-8666337	55	3	tehran	GPE
bjos-8666337	55	4	iran	GPE
bjos-8666337	56	1	15	CARDINAL
bjos-8666337	56	2	15	CARDINAL
bjos-8666337	58	1	3 koopaie	QUANTITY
bjos-8666337	58	2	braz j	PERSON
bjos-8666337	58	3	sci	ORG
bjos-8666337	59	1	2022;21	TIME
bjos-8666337	62	1	5 ml	QUANTITY
bjos-8666337	63	1	at least one hour	TIME
bjos-8666337	63	2	24 hours	TIME
bjos-8666337	63	3	collection1	PRODUCT
bjos-8666337	65	1	my09 / 11	PRODUCT
bjos-8666337	65	2	roche	ORG
bjos-8666337	65	3	mannheim	GPE
bjos-8666337	65	4	germany	GPE
bjos-8666337	66	1	nd-1000	ORG
bjos-8666337	66	2	260/280	CARDINAL
bjos-8666337	67	1	1.5 percent	PERCENT
bjos-8666337	67	2	20 °	QUANTITY
bjos-8666337	68	1	the my09 / my11	PRODUCT
bjos-8666337	68	2	5’-cgt	CARDINAL
bjos-8666337	68	3	ccm arr gga wac tga tc-3’	PERSON
bjos-8666337	68	4	5’-cgt	CARDINAL
bjos-8666337	68	5	cag	ORG
bjos-8666337	68	6	cat aay	PERSON
bjos-8666337	68	7	about 450	CARDINAL
bjos-8666337	68	8	types16	ORG
bjos-8666337	69	1	25	CARDINAL
bjos-8666337	69	2	10	CARDINAL
bjos-8666337	69	3	50	CARDINAL
bjos-8666337	69	4	200 ng	QUANTITY
bjos-8666337	69	5	2	CARDINAL
bjos-8666337	69	6	20 mm	QUANTITY
bjos-8666337	69	7	3 mm mgcl2	QUANTITY
bjos-8666337	70	1	5 minute	TIME
bjos-8666337	70	2	95 °	QUANTITY
bjos-8666337	70	3	35	CARDINAL
bjos-8666337	70	4	30 seconds	TIME
bjos-8666337	70	5	95 °	QUANTITY
bjos-8666337	70	6	30 seconds	TIME
bjos-8666337	70	7	55 °	QUANTITY
bjos-8666337	70	8	30 seconds	TIME
bjos-8666337	70	9	72 °	QUANTITY
bjos-8666337	70	10	72 °	QUANTITY
bjos-8666337	70	11	7 minutes	TIME
bjos-8666337	72	1	1 percent	PERCENT
bjos-8666337	73	1	hpv-16 e6	ORG
bjos-8666337	73	2	the hpv-16 e6	ORG
bjos-8666337	73	3	762	CARDINAL
bjos-8666337	73	4	1	CARDINAL
bjos-8666337	74	1	50	CARDINAL
bjos-8666337	74	2	10	CARDINAL
bjos-8666337	74	3	50	CARDINAL
bjos-8666337	74	4	200 ng	QUANTITY
bjos-8666337	74	5	2	CARDINAL
bjos-8666337	74	6	20 mm	QUANTITY
bjos-8666337	74	7	3 mm mgcl2	QUANTITY
bjos-8666337	75	1	5 minutes	TIME
bjos-8666337	75	2	95 °	QUANTITY
bjos-8666337	75	3	40	CARDINAL
bjos-8666337	75	4	95 °	QUANTITY
bjos-8666337	75	5	30 seconds	TIME
bjos-8666337	75	6	55 °	QUANTITY
bjos-8666337	75	7	50 seconds	TIME
bjos-8666337	75	8	72 °	QUANTITY
bjos-8666337	75	9	50 seconds	TIME
bjos-8666337	75	10	72 °	QUANTITY
bjos-8666337	75	11	10 minutes	TIME
bjos-8666337	77	1	1 percent	PERCENT
bjos-8666337	78	1	hpv-16 l1 gene	ORG
bjos-8666337	78	2	hpv-16 l1 gene	ORG
bjos-8666337	78	3	1	CARDINAL
bjos-8666337	78	4	7932	CARDINAL
bjos-8666337	79	1	4 koopaie et al	QUANTITY
bjos-8666337	79	2	braz j	PERSON
bjos-8666337	79	3	sci	ORG
bjos-8666337	80	1	2022;21	TIME
bjos-8666337	80	2	1	CARDINAL
bjos-8666337	81	1	hpv-16 e6	ORG
bjos-8666337	81	2	hpv-18 e6	ORG
bjos-8666337	81	3	5’-cga	CARDINAL
bjos-8666337	81	4	taa aag cag ac-3’	ORG
bjos-8666337	82	1	5’-tag	CARDINAL
bjos-8666337	82	2	att	ORG
bjos-8666337	82	3	atg gtt tct	PERSON
bjos-8666337	82	4	tgc ctg tat aca cgg gtc-3	ORG
bjos-8666337	82	5	hpv-16 l1	ORG
bjos-8666337	82	6	5’-tta	CARDINAL
bjos-8666337	82	7	ctt cct ggc acg tac acg	PERSON
bjos-8666337	82	8	hpv-16 l1	ORG
bjos-8666337	82	9	5’-atg	CARDINAL
bjos-8666337	82	10	gcg cgc ttt	PERSON
bjos-8666337	82	11	hpv-18	ORG
bjos-8666337	82	12	5’tta	CARDINAL
bjos-8666337	82	13	ctg	ORG
bjos-8666337	82	14	hpv-18	ORG
bjos-8666337	82	15	tgc ctg	ORG
bjos-8666337	82	16	aca cgg gtc	ORG
bjos-8666337	82	17	hpv-18	ORG
bjos-8666337	82	18	5’tta	CARDINAL
bjos-8666337	82	19	ctt cct ggc acg tac acg	PERSON
bjos-8666337	82	20	hpv-18	ORG
bjos-8666337	82	21	hpv-16 e6	ORG
bjos-8666337	82	22	1	CARDINAL
bjos-8666337	83	1	1	CARDINAL
bjos-8666337	84	1	hpv-16 e6.	ORG
bjos-8666337	85	1	hpv-18	ORG
bjos-8666337	85	2	hpv-18	ORG
bjos-8666337	85	3	835	CARDINAL
bjos-8666337	85	4	2	CARDINAL
bjos-8666337	86	1	50-l	CARDINAL
bjos-8666337	86	2	10	CARDINAL
bjos-8666337	86	3	50	CARDINAL
bjos-8666337	86	4	200 ng	QUANTITY
bjos-8666337	86	5	2	CARDINAL
bjos-8666337	86	6	20 mm	QUANTITY
bjos-8666337	86	7	3 mm mgcl2	QUANTITY
bjos-8666337	87	1	5 minutes	TIME
bjos-8666337	87	2	95 °	QUANTITY
bjos-8666337	87	3	40	CARDINAL
bjos-8666337	87	4	95 °	QUANTITY
bjos-8666337	87	5	30 seconds	TIME
bjos-8666337	87	6	55 °	QUANTITY
bjos-8666337	87	7	50 seconds	TIME
bjos-8666337	87	8	72 °	QUANTITY
bjos-8666337	87	9	50 seconds	TIME
bjos-8666337	87	10	72 °	QUANTITY
bjos-8666337	87	11	10 minutes	TIME
bjos-8666337	89	1	1%	PERCENT
bjos-8666337	90	1	5	CARDINAL
bjos-8666337	90	2	braz j	PERSON
bjos-8666337	90	3	sci	ORG
bjos-8666337	91	1	2022;21	TIME
bjos-8666337	91	2	hpv-18	ORG
bjos-8666337	91	3	hpv-18	ORG
bjos-8666337	91	4	7857	DATE
bjos-8666337	91	5	1	CARDINAL
bjos-8666337	92	1	the hpv-16 e6	ORG
bjos-8666337	92	2	2	CARDINAL
bjos-8666337	93	1	2	CARDINAL
bjos-8666337	93	2	hpv-18	ORG
bjos-8666337	93	3	r. abi	PERSON
bjos-8666337	93	4	377	CARDINAL
bjos-8666337	93	5	biosystems foster city	PERSON
bjos-8666337	93	6	canada	GPE
bjos-8666337	93	7	hpv-18	ORG
bjos-8666337	94	1	geneali	NORP
bjos-8666337	94	2	seoul	GPE
bjos-8666337	94	3	south korea	GPE
bjos-8666337	95	1	a1-4	PRODUCT
bjos-8666337	96	1	6	CARDINAL
bjos-8666337	97	1	hpv-18	ORG
bjos-8666337	97	2	hpv-18	ORG
bjos-8666337	97	3	1000	CARDINAL
bjos-8666337	97	4	1000	CARDINAL
bjos-8666337	98	1	hpv-18	ORG
bjos-8666337	98	2	genbank	ORG
bjos-8666337	98	3	hpv-18	ORG
bjos-8666337	98	4	6	CARDINAL
bjos-8666337	99	1	braz j	PERSON
bjos-8666337	99	2	sci	ORG
bjos-8666337	100	1	2022;21	TIME
bjos-8666337	100	2	30	CARDINAL
bjos-8666337	100	3	a year	DATE
bjos-8666337	100	4	march 2020 to march 2021	DATE
bjos-8666337	101	1	ten	CARDINAL
bjos-8666337	101	2	five	CARDINAL
bjos-8666337	102	1	9	CARDINAL
bjos-8666337	102	2	6	CARDINAL
bjos-8666337	103	1	53.84±13.61	CARDINAL
bjos-8666337	104	1	four	CARDINAL
bjos-8666337	104	2	tongue scc	ORG
bjos-8666337	104	3	six	CARDINAL
bjos-8666337	104	4	three	CARDINAL
bjos-8666337	104	5	two	CARDINAL
bjos-8666337	105	1	3	CARDINAL
bjos-8666337	105	2	hpv-16	ORG
bjos-8666337	105	3	hpv-18	ORG
bjos-8666337	105	4	e6	ORG
bjos-8666337	106	1	hpv-18	ORG
bjos-8666337	106	2	4-d	QUANTITY
bjos-8666337	107	1	4-d	QUANTITY
bjos-8666337	107	2	4	CARDINAL
bjos-8666337	108	1	7	CARDINAL
bjos-8666337	108	2	braz j	PERSON
bjos-8666337	108	3	sci	ORG
bjos-8666337	109	1	2022;21	TIME
bjos-8666337	109	2	4	CARDINAL
bjos-8666337	111	1	w	GPE
bjos-8666337	112	1	o	DATE
bjos-8666337	113	1	6	CARDINAL
bjos-8666337	113	2	8	CARDINAL
bjos-8666337	113	3	nk s ho w ed th	PERSON
bjos-8666337	113	4	vi ru s st ra	PERSON
bjos-8666337	115	1	om th e pa	PERSON
bjos-8666337	115	2	lo ng s	PERSON
bjos-8666337	115	3	li ne ag	ORG
bjos-8666337	116	1	li ne ag	ORG
bjos-8666337	117	1	8	CARDINAL
bjos-8666337	117	2	braz j	PERSON
bjos-8666337	117	3	sci	ORG
bjos-8666337	118	1	2022;21	TIME
bjos-8666337	119	1	hnscc2	ORG
bjos-8666337	121	1	labor3	PERSON
bjos-8666337	123	1	population4	DATE
bjos-8666337	124	1	annual	DATE
bjos-8666337	125	1	pathogenesis5	NORP
bjos-8666337	127	1	20 – 40 %	PERCENT
bjos-8666337	127	2	hnscc6	ORG
bjos-8666337	130	1	4/6	CARDINAL
bjos-8666337	131	1	hpv e6 protein promotes	ORG
bjos-8666337	131	2	gene8	PERSON
bjos-8666337	132	1	better9	PERSON
bjos-8666337	133	1	hpv-18	ORG
bjos-8666337	133	2	iranian	NORP
bjos-8666337	135	1	hpv-18	ORG
bjos-8666337	135	2	azerbaijan	GPE
bjos-8666337	135	3	iran	GPE
bjos-8666337	136	1	delavarian	PERSON
bjos-8666337	137	1	sisk et al.15	PERSON
bjos-8666337	138	1	44.4%	PERCENT
bjos-8666337	138	2	cancers16	ORG
bjos-8666337	141	1	iran	GPE
bjos-8666337	142	1	study18	ORG
bjos-8666337	145	1	98%	PERCENT
bjos-8666337	148	1	9	CARDINAL
bjos-8666337	148	2	braz j	PERSON
bjos-8666337	148	3	sci	ORG
bjos-8666337	149	1	2022;21	TIME
bjos-8666337	149	2	imam khomeini hospital	PERSON
bjos-8666337	149	3	tehran university of medical sciences	ORG
bjos-8666337	149	4	tehran university of medical sciences	ORG
bjos-8666337	151	1	md	GPE
bjos-8666337	152	1	md	GPE
bjos-8666337	154	1	md	GPE
bjos-8666337	156	1	md	GPE
bjos-8666337	158	1	1	CARDINAL
bjos-8666337	158	2	jasim h	ORG
bjos-8666337	158	3	ernberg m.	PERSON
bjos-8666337	159	1	sci rep	ORG
bjos-8666337	159	2	2018 feb 19;8(1):3220	DATE
bjos-8666337	159	3	10.1038	CARDINAL
bjos-8666337	159	4	2	CARDINAL
bjos-8666337	160	1	wang s	PERSON
bjos-8666337	160	2	zhuang x	PERSON
bjos-8666337	160	3	gao	PERSON
bjos-8666337	160	4	qiao t.	PERSON
bjos-8666337	161	1	onco	PERSON
bjos-8666337	162	1	2021	CARDINAL
bjos-8666337	162	2	feb 5;14:867-77	DATE
bjos-8666337	163	1	10.2147	CARDINAL
bjos-8666337	164	1	3	CARDINAL
bjos-8666337	164	2	klussmann jp	PERSON
bjos-8666337	164	3	san giorgi	PERSON
bjos-8666337	166	1	2021	CARDINAL
bjos-8666337	166	2	22;39(17):2344-2350	DATE
bjos-8666337	167	1	10.1016	CARDINAL
bjos-8666337	168	1	4	CARDINAL
bjos-8666337	168	2	mcdermott jd	PERSON
bjos-8666337	168	3	bowles dw	PERSON
bjos-8666337	170	1	curr	PERSON
bjos-8666337	171	1	2019;20(5):1	CARDINAL
bjos-8666337	172	1	10.1007	CARDINAL
bjos-8666337	172	2	5	CARDINAL
bjos-8666337	172	3	boscolo-rizzo	PERSON
bjos-8666337	172	4	zorzi m	PERSON
bjos-8666337	172	5	da mosto mc	PERSON
bjos-8666337	172	6	tirelli g	GPE
bjos-8666337	173	1	italy	GPE
bjos-8666337	174	1	plos	PERSON
bjos-8666337	174	2	one	CARDINAL
bjos-8666337	175	1	2018;13(2):e0192621	CARDINAL
bjos-8666337	175	2	10.1371/journal.pone.0192621	MONEY
bjos-8666337	175	3	kofler	PERSON
bjos-8666337	175	4	bruckmoser e	PERSON
bjos-8666337	178	1	2020;12(5):1192	CARDINAL
bjos-8666337	179	1	10.3390	CARDINAL
bjos-8666337	180	1	augustin jg	PERSON
bjos-8666337	180	2	morini	PERSON
bjos-8666337	182	1	sep 15;10:1751	DATE
bjos-8666337	183	1	10.3389	CARDINAL
bjos-8666337	184	1	8	CARDINAL
bjos-8666337	185	1	rodriguez j	PERSON
bjos-8666337	185	2	li s	PERSON
bjos-8666337	185	3	wynne k	PERSON
bjos-8666337	185	4	359	CARDINAL
bjos-8666337	186	1	31;24(5):1316-29	DATE
bjos-8666337	187	1	10.1016	CARDINAL
bjos-8666337	188	1	kobayashi k	PERSON
bjos-8666337	191	1	10	CARDINAL
bjos-8666337	191	2	braz j	PERSON
bjos-8666337	191	3	sci	ORG
bjos-8666337	192	1	2022;21	TIME
bjos-8666337	192	2	10	CARDINAL
bjos-8666337	193	1	ia	GPE
bjos-8666337	194	1	iranian	NORP
bjos-8666337	195	1	2012;5(1):21	CARDINAL
bjos-8666337	195	2	10.1200	CARDINAL
bjos-8666337	196	1	11	CARDINAL
bjos-8666337	196	2	seifi	PERSON
bjos-8666337	196	3	ia	GPE
bjos-8666337	196	4	kermani aa	PERSON
bjos-8666337	197	1	azerbaijan	GPE
bjos-8666337	197	2	iran	GPE
bjos-8666337	198	1	iran	GPE
bjos-8666337	199	1	2013;42(1):79-85	DATE
bjos-8666337	199	2	12	CARDINAL
bjos-8666337	200	1	van cleef p	ORG
bjos-8666337	200	2	de wilde	ORG
bjos-8666337	202	1	seven	CARDINAL
bjos-8666337	204	1	2008	DATE
bjos-8666337	206	1	10.1007	CARDINAL
bjos-8666337	206	2	13	CARDINAL
bjos-8666337	207	1	wood zc	PERSON
bjos-8666337	207	2	smith dd	PERSON
bjos-8666337	208	1	j gen virol	PERSON
bjos-8666337	209	1	2017	CARDINAL
bjos-8666337	209	2	26	CARDINAL
bjos-8666337	211	1	14	CARDINAL
bjos-8666337	212	1	delavarian	PERSON
bjos-8666337	213	1	khorasan	GPE
bjos-8666337	213	2	iran	GPE
bjos-8666337	214	1	sci	PERSON
bjos-8666337	214	2	2010;10(11):981-5	CARDINAL
bjos-8666337	214	3	10.3923	CARDINAL
bjos-8666337	215	1	15	CARDINAL
bjos-8666337	215	2	sisk ea	PERSON
bjos-8666337	215	3	soltys sg	GPE
bjos-8666337	215	4	zhu s	PERSON
bjos-8666337	215	5	fisher sg	PERSON
bjos-8666337	215	6	te.bradford cr	MONEY
bjos-8666337	218	1	2002;24(9):841-49	CARDINAL
bjos-8666337	219	1	16	CARDINAL
bjos-8666337	220	1	jalilvand s	PERSON
bjos-8666337	220	2	r.	NORP
bjos-8666337	220	3	iran	GPE
bjos-8666337	221	1	asian	NORP
bjos-8666337	222	1	2014;15(17):7029-35	CARDINAL
bjos-8666337	223	1	17	CARDINAL
bjos-8666337	223	2	kreimer ar	PERSON
bjos-8666337	223	3	johansson m	PERSON
bjos-8666337	223	4	chang-claude j	PERSON
bjos-8666337	224	1	j clin oncol	PERSON
bjos-8666337	225	1	2013;31(21):2708	CARDINAL
bjos-8666337	225	2	18	CARDINAL
bjos-8666337	225	3	salehiniya h.abbaszadeh h. prevalence	ORG
bjos-8666337	225	4	iran	GPE
bjos-8666337	227	1	2021;93(11):6089-99	ORG
bjos-8666337	228	1	toh zq	PERSON
bjos-8666337	228	2	kosasih j	PERSON
bjos-8666337	228	3	russell fm	PERSON
bjos-8666337	228	4	garland sm	PERSON
bjos-8666337	231	1	2019;12:1951	CARDINAL